⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

PODD

Insulet Corporation

Healthcare · Medical Devices

137.92USD

-4.3600 (-3.06%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 137.92
P/E26.3
Dvd Ind Yld—
P/B6.94
P/S3.2
Curr EV/T12M EBITDA17.3
Mkt Cap (USD)9.9B
Curr EV (USD)10.6B
2)

Per Share Data

EPS T12M5.32
DPS—
Bk Val Per Sh20.51
Rev/Sh44.00
Cash/Sh7.71
Curr Shares Out69.4M
FCF/Sh4.23
3)

Cash Flow Analysis

P/CF19.3
Curr P/FCF33.6
CF/NI1.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales16.7%
Eff Interest Rate24.5%
4)

Growth Potential

Dil EPS 1Y Gr-39.8%
Cap 1Y Gr18.4%
BPS 1Y Gr28.5%
R&D To Sales11.3%
Retention Rate100.0%
Rev 1Y Gr30.7%
FCF 1Y Gr23.7%
Assets 1Y Gr3.3%
5)

Profitability

EBITDA0.6B
EBIT0.5B
Operating Margin16.9%
Pretax Margin16.2%
Net Margin12.3%
ROA11.3%
ROE26.0%
ROC13.9%
Asset Turnover0.92
6)

Structure

Current Ratio2.48
Quick Ratio1.51
Debt/Assets43.8%
Debt/Com Eq97.6%
Net Debt/EBITDA0.86
Tot Debt/Capital49.4%
Gross Margin71.1%
EBIT/Int Exp8.8

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.